The FDA previously placed two clinical studies on hold, including the Phase III trial in which the liver toxicity occurred.

Shares of Intellia Therapeutics (NTLA) crashed ~28% in the premarket on Friday after the company disclosed that a patient who ...

Sarajevo: The death toll from a nursing home blaze in Bosnia earlier this week rose to 13 after a woman died from her injuries overnight, a hospital ...

ROCKFORD, Ill. (WIFR) - Emergency Medical Service (EMS) professionals must make quick decisions in the field; it can mean ...

When the kidneys are damaged—after surgery, cardiac arrest, or as a side effect of certain medications—doctors often face one ...

Only 200,000, or 3%, are diagnosed with Alzheimer's before age 65. Such an early onset means the disease is more likely to ...

An estimated 50% of patients with SLE will develop lupus nephritis in their lifetime, with people of African descent more ...

There are stark socioeconomic and ethnic inequalities in babies admitted to and who die in neonatal units in England and ...

Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability ...

At 69 years old, Debby Orcutt was diagnosed last year with pancreatic cancer, a condition so dire that her doctor refused to ...

Among over 151,000 patients, use of GLP-1 drugs was linked to a lower risk of death compared with no use (adjusted HR 0.77, 95% CI 0.70-0.85, P <0.001), reported Babak J. Orandi, MD, PhD, MSc, of NYU ...

Lifileucel shows a 25.6% objective response rate and 71.8% disease control rate in advanced nonsquamous NSCLC patients, ...